Abstract
LT, LIGHT, and TNF are core family members of the TNFR superfamily of cytokines. LT and LIGHT, produced primarily by lymphocytes, interact with LTβR expressed by stromal and epithelial cells. Extensive studies over the last decade have revealed a critical role of LT-LTβR interactions for organogenesis and maintenance of the secondary lymphoid organs and in the generation of an efficient humoral immune response to various pathogens. LTβRs function beyond the lymphoid organs shows valuable potential yet remains largely undefined. Recent studies indicate that LTβR signaling is required for liver regeneration, hepatitis, and hepatic lipid metabolism. The balance of beneficial and detrimental effects of LTβR is critical for understanding the mechanisms of autoimmune disease and liver function and may open a new avenue for therapeutic intervention. This review will discuss recent advances in understanding LTβRs role in various human and murine disease models while focusing on its regulation of and implications in various liver related diseases.
Keywords: Lymphotoxin, lymphotoxin beta receptor, tumor necrosis factor, LIGHT, atherosclerosis, lipid metabolism, hepatic lipase
Current Molecular Medicine
Title: The Role of Lymphotoxin Receptor Signaling in Diseases
Volume: 7 Issue: 6
Author(s): Alexei V. Tumanov, Peter A. Christiansen and Yang-Xin Fu
Affiliation:
Keywords: Lymphotoxin, lymphotoxin beta receptor, tumor necrosis factor, LIGHT, atherosclerosis, lipid metabolism, hepatic lipase
Abstract: LT, LIGHT, and TNF are core family members of the TNFR superfamily of cytokines. LT and LIGHT, produced primarily by lymphocytes, interact with LTβR expressed by stromal and epithelial cells. Extensive studies over the last decade have revealed a critical role of LT-LTβR interactions for organogenesis and maintenance of the secondary lymphoid organs and in the generation of an efficient humoral immune response to various pathogens. LTβRs function beyond the lymphoid organs shows valuable potential yet remains largely undefined. Recent studies indicate that LTβR signaling is required for liver regeneration, hepatitis, and hepatic lipid metabolism. The balance of beneficial and detrimental effects of LTβR is critical for understanding the mechanisms of autoimmune disease and liver function and may open a new avenue for therapeutic intervention. This review will discuss recent advances in understanding LTβRs role in various human and murine disease models while focusing on its regulation of and implications in various liver related diseases.
Export Options
About this article
Cite this article as:
Tumanov V. Alexei, Christiansen A. Peter and Fu Yang-Xin, The Role of Lymphotoxin Receptor Signaling in Diseases, Current Molecular Medicine 2007; 7 (6) . https://dx.doi.org/10.2174/156652407781695701
DOI https://dx.doi.org/10.2174/156652407781695701 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design Signaling Pathways Associated with Inflammatory Bowel Disease
Recent Patents on Inflammation & Allergy Drug Discovery Regulatory T Cell Therapy for Type I Diabetes Targeting on β Cell Associated Autoantigens
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Monoclonal Antibodies: A Review
Current Clinical Pharmacology Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Current Medicinal Chemistry siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Current Pharmaceutical Design Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Updates on GMSCs Treatment for Autoimmune Diseases
Current Stem Cell Research & Therapy Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
Current Pharmaceutical Design Recent Patents on the Treatment of Type 1 Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Dendritic Cell-Based Therapies in the Bench and the Bedsides
Current Drug Targets - Inflammation & Allergy Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Autoimmune Lymphoproliferative Syndrome (ALPS)
Current Pharmaceutical Design NKT Cells: A Regulator in Both Innate and Acquired Immunity
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Models of Antigen Receptor Activation in the Design of Vaccines
Current Pharmaceutical Design Vasculitis Following Influenza Vaccination: A Review of the Literature
Current Rheumatology Reviews Hepatitis C Viruss Immune Evasion Strategies
Current Immunology Reviews (Discontinued) Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry Cytokine Therapies in Crohns Disease: Where are We Now and where should We Go?
Inflammation & Allergy - Drug Targets (Discontinued)